Average Co-Inventor Count = 6.00
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Other (11 from 832,891 patents)
2. Esperion Therapeutics, Inc. (2 from 60 patents)
3. Pfizer Corporation (1 from 4,455 patents)
14 patents:
1. 7312190 - Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
2. 7307058 - Multimeric Apo A-I agonist compounds
3. 7250407 - Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
4. 7189689 - Apolipoprotein A-L agonists and their use to treat dyslipidemic disorders
5. 6844327 - Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
6. 6753313 - Multimeric Apoa-I agonist compounds
7. 6716816 - Multimeric Apo A-I agonist compounds
8. 6630450 - Method of treating dyslipidemia
9. 6602854 - Branched multimeric Apo A-I agonist compounds
10. 6573239 - Apolipoprotein A-I agonist compounds
11. 6518412 - Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
12. 6376464 - Lipid complexes of APO A-1 agonist compounds
13. 6329341 - Method of treating septic shock
14. 6004925 - Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders